A New Jersey-based healthcare company turned heads on Tuesday following HC Wainwright & Co. maintaining a buy rating while raising its price target from $7 to $10/share. This...

To read the full story on AllPennyStocks.com, click here.

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Protalix BioTherapeutics Charts.
Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Protalix BioTherapeutics Charts.